Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matthew Chau Hsien Ng (Matthew Ch Ng)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Chemotherapy Induced

Coronavirus Disease

Top Venues

Asia-Pacific journal of clinical oncology

Cancer research

National Cancer Centre Singapore

Institute of Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Centre Singapore Jan 2o 2013

Singapore

Chief GI oncology :: Medical Oncology

Education History

Institute of Cancer Research

United Kingdom

PHD

Publications

Omer An, Yangyang Song, Xinyu Ke, Jimmy Bok-Yan So, Raghav Sundar, Henry Yang, Sun Young Rha, Ming Hui Lee, Su Ting Tay, Xuewen Ong, Angie Lay Keng Tan, Matthew Chau Hsien Ng, Erwin Tantoso, Leilei Chen, Patrick Tan, Wei Peng Yong, null null
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy. Cancer research 81 (10) (2021)
Toshio Shimizu, Dong-Wan Kim, Herbert H Loong, Chia-Chi Lin, Matthew Chau Hsien Ng, Noboru Yamamoto, Brigette Ma, Daniel Sw Tan
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium. Asia-Pacific journal of clinical oncology 17 (4) (2021)
Justina Yick Ching Lam, Su Pin Choo, David Wai-Meng Tai, Iain Bee Huat Tan, Chee Kian Tham, Wen Hsin Koo, Simon Yew Kuang Ong, Soo Fan Ang, Clarinda Wei Ling Chua, Dawn Qingqing Chong, Patrick Tze Hern Teo, Christabel Jing Zhi Lee, Samuel Cheng En Ee, Matthew Chau Hsien Ng
What is the value of third-line chemotherapy in advanced gastroesophageal cancer? A 5-year retrospective analysis at a single center. Asia-Pacific journal of clinical oncology 16 (1) (2019)